Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Format: Artigo
Sprache:Russo
Veröffentlicht: «FIRMA «SILICEA» LLC 2004-12-01
Schriftenreihe:Российский кардиологический журнал
Schlagworte:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Online Zugang:https://russjcardiol.elpub.ru/jour/article/view/2326
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge